These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28202657)

  • 21. Rit contributes to nerve growth factor-induced neuronal differentiation via activation of B-Raf-extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades.
    Shi GX; Andres DA
    Mol Cell Biol; 2005 Jan; 25(2):830-46. PubMed ID: 15632082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sprouty-related Ena/vasodilator-stimulated phosphoprotein homology 1-domain-containing protein (SPRED1), a tyrosine-protein phosphatase non-receptor type 11 (SHP2) substrate in the Ras/extracellular signal-regulated kinase (ERK) pathway.
    Quintanar-Audelo M; Yusoff P; Sinniah S; Chandramouli S; Guy GR
    J Biol Chem; 2011 Jul; 286(26):23102-12. PubMed ID: 21531714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy.
    Steelman LS; Franklin RA; Abrams SL; Chappell W; Kempf CR; Bäsecke J; Stivala F; Donia M; Fagone P; Nicoletti F; Libra M; Ruvolo P; Ruvolo V; Evangelisti C; Martelli AM; McCubrey JA
    Leukemia; 2011 Jul; 25(7):1080-94. PubMed ID: 21494257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deciphering signaling pathways in vivo: the Ras/Raf/MEK/ERK cascade.
    Galabova-Kovacs G; Baccarini M
    Methods Mol Biol; 2010; 661():421-31. PubMed ID: 20811999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PI3 kinase is important for Ras, MEK and Erk activation of Epo-stimulated human erythroid progenitors.
    Schmidt EK; Fichelson S; Feller SM
    BMC Biol; 2004 May; 2():7. PubMed ID: 15149544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
    Hatzivassiliou G; Song K; Yen I; Brandhuber BJ; Anderson DJ; Alvarado R; Ludlam MJ; Stokoe D; Gloor SL; Vigers G; Morales T; Aliagas I; Liu B; Sideris S; Hoeflich KP; Jaiswal BS; Seshagiri S; Koeppen H; Belvin M; Friedman LS; Malek S
    Nature; 2010 Mar; 464(7287):431-5. PubMed ID: 20130576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma.
    Luan Z; He Y; Alattar M; Chen Z; He F
    Mol Cancer; 2014 Feb; 13():38. PubMed ID: 24568222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The EGF receptor activates ERK but not JNK Ras-dependently in basal conditions but ERK and JNK activation pathways are predominantly Ras-independent during cardiomyocyte stretch.
    Duquesnes N; Vincent F; Morel E; Lezoualc'h F; Crozatier B
    Int J Biochem Cell Biol; 2009 May; 41(5):1173-81. PubMed ID: 19015044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transforming growth factor β and Ras/MEK/ERK signaling regulate the expression level of a novel tumor suppressor Lefty.
    Miyata N; Azuma T; Hozawa S; Higuchi H; Yokoyama A; Kabashima A; Igarashi T; Saeki K; Hibi T
    Pancreas; 2012 Jul; 41(5):745-52. PubMed ID: 22441145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-Raf is required for the initiation of lung cancer by K-Ras(G12D).
    Karreth FA; Frese KK; DeNicola GM; Baccarini M; Tuveson DA
    Cancer Discov; 2011 Jul; 1(2):128-36. PubMed ID: 22043453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1Alpha,25-dihydroxyvitamin D3-mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc-mediated activation of the RAS/RAF/ERK-MAP kinase signalling pathway.
    Hughes PJ; Brown G
    J Cell Biochem; 2006 Jun; 98(3):590-617. PubMed ID: 16440327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
    Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
    Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The regulation of oncogenic Ras/ERK signalling by dual-specificity mitogen activated protein kinase phosphatases (MKPs).
    Kidger AM; Keyse SM
    Semin Cell Dev Biol; 2016 Feb; 50():125-32. PubMed ID: 26791049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma.
    Feng W; Brown RE; Trung CD; Li W; Wang L; Khoury T; Alrawi S; Yao J; Xia K; Tan D
    Ann Clin Lab Sci; 2008; 38(3):195-209. PubMed ID: 18715846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Ras-ERK pathway: understanding site-specific signaling provides hope of new anti-tumor therapies.
    Calvo F; Agudo-Ibáñez L; Crespo P
    Bioessays; 2010 May; 32(5):412-21. PubMed ID: 20414899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CrkL plays a role in SDF-1-induced activation of the Raf-1/MEK/Erk pathway through Ras and Rac to mediate chemotactic signaling in hematopoietic cells.
    Arai A; Aoki M; Weihua Y; Jin A; Miura O
    Cell Signal; 2006 Dec; 18(12):2162-71. PubMed ID: 16781119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular pathways: adaptive kinome reprogramming in response to targeted inhibition of the BRAF-MEK-ERK pathway in cancer.
    Johnson GL; Stuhlmiller TJ; Angus SP; Zawistowski JS; Graves LM
    Clin Cancer Res; 2014 May; 20(10):2516-22. PubMed ID: 24664307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
    Roberts PJ; Der CJ
    Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic Validation of Cell Proliferation via Ras-Independent Activation of the Raf/Mek/Erk Pathway.
    Lechuga CG; Simón-Carrasco L; Jacob HK; Drosten M
    Methods Mol Biol; 2017; 1487():269-276. PubMed ID: 27924574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncogenic Ras abrogates MEK SUMOylation that suppresses the ERK pathway and cell transformation.
    Kubota Y; O'Grady P; Saito H; Takekawa M
    Nat Cell Biol; 2011 Mar; 13(3):282-91. PubMed ID: 21336309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.